DEA Archived Press Releases

Press Releases before January 20, 2025
612 Results - Showing 311 to 320
PRESS RELEASE

DEA achieves significant milestone during 16th National Prescription Drug Take Back Day

SAN DIEGO – With the robust participation of Americans nationwide, DEA and its law enforcement partners have now surpassed its 10 million pound goal and collected nearly 11 million pounds of unused, unwanted or expired prescription medications over the course of 16 successful DEA National Prescription Drug Take Back events...
PRESS RELEASE

Former leader of Kenyan organized crime family and his brother plead guilty to narcotics, weapons, and obstruction offenses

NEW YORK - Raymond P. Donovan, the Special Agent in Charge of the DEA Special Operations Division and Geoffrey S. Berman, the United States Attorney for the Southern District of New York announced that Baktash Akasha Abdalla, aka “Baktash Akasha,” and Ibrahim Akasha Abdalla, aka “Ibrahim Akasha,” pled guilty yesterday...
PRESS RELEASE

DEA and partners hold National Prescription Drug Take Back Day on October 27

SAN DIEGO – After collecting a total of more than 9.9 million pounds (nearly 5,000 tons) of expired, unused and unwanted prescription medications during 15 previous events over the past eight years, the Drug Enforcement Administration expects to reach a total of 10 million pounds collected following the upcoming fall...
PRESS RELEASE

DEA and partners hold National Prescription Drug Take Back Day on October 27

WASHINGTON – After collecting a total of more than 9.9 million pounds (nearly 5,000 tons) of expired, unused and unwanted prescription medications during 15 previous events over the past eight years, the Drug Enforcement Administration expects to reach a total of 10 million pounds collected following the upcoming fall 2018...
PRESS RELEASE

DEA to kick off annual Red Ribbon Campaign

WASHINGTON – The United States Drug Enforcement Administration is gearing up to kick off its annual Red Ribbon Campaign, the nation’s largest drug prevention effort, which launches October 23. The National Red Ribbon Campaign began after drug traffickers in Mexico tortured and brutally murdered Special Agent Enrique “Kiki” Camarena in...
PRESS RELEASE

Justice, Treasury, and State Departments announce coordinated enforcement efforts against Cartel Jalisco Nueva Generacion

WASHINGTON – The United States of America, through its Departments of Justice, Treasury, and State announced today a series of measures to target and dismantle the Cartel Jalisco Nueva Generacion (CJNG) – one of the largest, most dangerous drug cartels currently operating in Mexico. These measures include the unsealing of...
PRESS RELEASE

DEA Acting Administrator underscores the importance of drug enforcement efforts to combat opioid epidemic

SALT LAKE CITY – DEA Acting Administrator Uttam Dhillon today highlighted the significance of law enforcement as part of a successful, comprehensive solution to the opioid epidemic, stressing efforts aimed at those supplying communities with deadly, addictive drugs. Acting Administrator Dhillon delivered remarks to hundreds of medical practitioners, drug treatment...
PRESS RELEASE

Suspected online drug dealer indicted in fentanyl overdose death

SAN DIEGO – Suspected drug dealer Trevon Lucas was indicted by a federal grand jury for distributing fentanyl that caused the death of a La Jolla resident, identified only as C.A.S. in court filings. According to statements made by prosecutors at his detention hearing yesterday, C.A.S. was found dead in...
PRESS RELEASE

DEA joins HHS, ONDCP for listening session with nationwide drug prescribers to discuss concerns and solutions

WASHINGTON – DEA’s head of Diversion Control today joined with senior Department of Health & Human Services and Office of National Drug Control Policy officials to host a listening session with health care provider groups who represent drug prescribers nationwide. The purpose of the summit was to hear concerns and...
PRESS RELEASE

FDA-approved drug Epidiolex placed in schedule V of Controlled Substance Act

WASHINGTON - The Department of Justice and Drug Enforcement Administration today announced that Epidiolex, the newly approved medication by the Food & Drug Administration, is being placed in schedule V of the Controlled Substances Act, the least restrictive schedule of the CSA. In June 2018, the FDA announced it approved...